| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 88.09 | 0.64 (+0.73%) | 61.71 - 88.20 | 11.4 million (Above Avg) |
Market data as of 4:02PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 87.47 |
|---|---|
| Previous Close | 87.45 |
| Day's Range | 87.41 - 88.20 |
| Market Cap | 247.4B |
| Avg Volume (10 Day) | 9.3M |
| Price/Earnings (Trailing 12 Mo.) | 24.0x |
| Earnings Per Share (Trailing 12 Mo.) | 3.67 |
| Dividend Yield | 0.66 (3.00%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter
Business Wire - Monday 05/13/2013 5:16 PM ET
First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial Fibrillation
Business Wire - Thursday 05/09/2013 9:49 AM ET
Biosense Webster Showcases Cutting Edge Innovation and Leadership in AF Ablation at HRS Annual Scientific Sessions 2013
Business Wire - Wednesday 05/08/2013 8:50 AM ET
Davis Names Top 25 Brand Leaders for 2012
Business Wire - Tuesday 05/07/2013 6:00 AM ET
Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
PR Newswire - Thursday 05/02/2013 5:00 PM ET
First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting
Business Wire - Wednesday 05/01/2013 3:05 PM ET
First Manhattan Comments on Addition to Vivus’ Board of Directors
Business Wire - Wednesday 05/01/2013 8:34 AM ET
Johnson & Johnson Announces Dividend Increase of 8.2%
PR Newswire - Thursday 04/25/2013 10:37 AM ET
| JNJ | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 5.53% | |
| Net Income Growth (1yr) | 213.15% | |
| Total Debt/Equity | 0.24 | |
| LT Debt/Equity | 0.17 | |
| Earnings Yield | 4.17% | |
| Price/Sales | 3.61 |
| Company | Last | Change |
|---|---|---|
| Pfizer Inc | 28.96 | -0.99% |
| Novartis AG | 74.15 | -1.15% |
| Sanofi SA | 54.50 | +0.53% |
| GlaxoSmithKline PLC | 52.22 | +0.21% |
| Merck & Co Inc | 45.99 | -0.82% |
Data is delayed by at least 15 min.